- CA$4.71bn
- CA$4.25bn
- $1.93bn
- 92
- 72
- 32
- 71
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,156 | 1,789 | 1,762 | 1,733 | 1,934 |
Cost of Revenue | |||||
Gross Profit | 450 | 958 | 769 | 604 | 780 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 648 | 736 | 1,048 | 1,230 | 1,607 |
Operating Profit | 508 | 1,053 | 715 | 502 | 327 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 482 | 1,034 | 726 | 531 | 320 |
Provision for Income Taxes | |||||
Net Income After Taxes | 309 | 672 | 461 | 287 | 41.6 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 293 | 628 | 420 | 253 | 10.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 293 | 628 | 420 | 253 | 10.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.197 | 0.496 | 0.386 | 0.243 | 0.194 |
Dividends per Share |